Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Guidance on communication and informed consent with patients and their families for experimental individualized treatments.

American journal of human genetics·2026
Same author

Die Anaesthesiologie·2026
Same author

Sex and Gender Differences in Chronic Kidney Disease-Explained by the Brenner-Luyckx Concept of Hyperfiltration.

Journal of clinical medicine·2026
Same author

[Assisted suicide in Germany-initial analysis of data from a reporting platform and potential implications for the development of a guideline].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2026
Same author

Beneficence-Based Obligations and Ethics Consultation in Assisted Dying.

Bioethics·2025
Same author

[Treatment goal and patients' wishes: Ethical foundations of decision-making].

MMW Fortschritte der Medizin·2025

Related Experiment Video

Updated: Jul 13, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

[Financial incentives and dialysis].

Frieder Keller1, Harald Dress, Andreas Mertz

  • 1Nephrologie und Dialyse Fachpflege, Medizinische Fakultät, Universität Ulm, Ulm.

Medizinische Klinik (Munich, Germany : 1983)
|August 19, 2007
PubMed
Summary

High-cost hemodialysis is a cost-effective treatment, but financial incentives in nephrology may hinder complex care and kidney transplantation. A shift towards prevention and cost-effective strategies is needed.

Area of Science:

  • Nephrology
  • Health Economics

Context:

  • Chronic renal replacement therapy, particularly hemodialysis, presents significant costs ($55,000 Euros/year), representing a high but cost-effective treatment threshold.
  • Current reimbursement structures ensure dialysis access for all patients but create economic disincentives for nephrologists regarding complex treatments like immunosuppression for IgA nephritis.
  • The nephrology field faces a "progress trap" where financial incentives may conflict with optimal patient care, including decisions about dialysis withdrawal and kidney transplantation referrals.

Purpose:

  • To analyze the economic challenges within nephrology and their impact on clinical decision-making.
  • To explore the conflict between high-tech medical financing and the need for cost-effective kidney disease management.
  • To advocate for a reevaluation of financial incentives and a shift towards prevention and cost-effective kidney transplantation.

Related Experiment Videos

Last Updated: Jul 13, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

Summary:

  • Hemodialysis, while cost-effective, is expensive, leading to high utilization. However, financial pressures may discourage nephrologists from pursuing complex treatments or timely kidney transplantation referrals.
  • The high cost of advanced medical procedures necessitates a critical review of healthcare financing, pushing for greater emphasis on preventive measures and cost-effective interventions.
  • Discussions on extending the utility of kidney transplantation should occur without moral rigidity, acknowledging the economic competition with other medical disciplines.

Impact:

  • Highlights the need for a paradigm shift in nephrology to prioritize cost-effectiveness and prevention.
  • Suggests that financial incentives in healthcare may inadvertently influence clinical decisions, potentially compromising patient outcomes.
  • Underscores the importance of open dialogue regarding the financing of high-tech medicine and the future of kidney disease management.